Live feed
Filing
SC 13G/A
SC 13G/A0000902664-19-001007·Mirati Therapeutics, Inc.
Schedule 13G ownership disclosure
Mirati Therapeutics Inc
Security class unavailable · CUSIP: 60468T105
Event date: 2018-12-31
Legacy cover-page extraction is best effort and may not include every reporting person.
- Filing-level shares
- 4,798,101
- Percent of class
- 14.7600%
Amounts are as disclosed in this filing. Schedule type alone does not establish investment intent.
Source: SEC EDGAR filingFiling metadata
- Accession number
- 0000902664-19-001007
- Form type
- SC 13G/A
- Filer
- Mirati Therapeutics, Inc.
- CIK
- CIK 1576263
- Filed
- Feb 14, 2019
- Reporting period
- Dec 31, 2018
- Description
- Schedule 13G beneficial ownership